{"id":13,"date":"2025-12-04T20:02:43","date_gmt":"2025-12-04T20:02:43","guid":{"rendered":"https:\/\/www.ptcbio.ca\/fr\/homepage\/"},"modified":"2026-03-05T12:46:35","modified_gmt":"2026-03-05T17:46:35","slug":"homepage","status":"publish","type":"page","link":"https:\/\/www.ptcbio.ca\/fr\/","title":{"rendered":"Page D’accueil"},"content":{"rendered":"
\n\t\n\t\t
\n\t\n\t\t\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\n\t<\/picture>\n\t
Katie, vivent avec la PCU, \u00c9tats-Unis\n<\/div><\/figcaption>\n\t<\/figure>\n\t\n\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\tTraduire la science<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tTransformer des vies<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/h1>\n\t\t\t\t\t\t\t\t\t\t\t\t\t
Offrir des traitements transformateurs aux patients de tous \u00e2ges atteints de maladies rares aux besoins non satisfaits<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\t
\n\t
    \n\t\t\t\t\t\t\t\t\t
  1. \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tPage D’accueil<\/span>\n\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t
  2. \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\tPage D’accueil<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ol>\n<\/nav>\n<\/div>\n\n\n
    \n\t\t
    \n\n\t\t\n\t\t\t\t\t

    \n\t\t\t\tL\u2019innovation, port\u00e9e par la science et une passion au service des patients<\/span>\n\t\t\t<\/h3>\n\t\t\n\t\t
    \n\t\t\t

    PTC est une entreprise biopharmaceutique mondiale qui d\u00e9couvre, d\u00e9veloppe et commercialise des m\u00e9dicaments cliniquement diff\u00e9renci\u00e9s. Ces traitements s\u2019adressent aux enfants et aux adultes atteints de maladies graves pour lesquelles les besoins m\u00e9dicaux demeurent non combl\u00e9s. Notre capacit\u00e9 \u00e0 rep\u00e9rer de nouvelles th\u00e9rapies innovantes et \u00e0 commercialiser des m\u00e9dicaments partout dans le monde est la base qui soutient l\u2019investissement dans un portefeuille diversifi\u00e9.<\/p>\n\t\t<\/div>\n\n\t\t\n\t\t\n\t<\/div>\n<\/div>\n\n\n\n\n\t\n<\/svg>\n\n\n

    \n\t\t
    \n\n\t\t\t\t\t
    \n\t\t\t\tNos m\u00e9dicaments\t\t\t<\/div>\n\t\t\n\t\t\t\t\t

    \n\t\t\t\tUne science r\u00e9volutionnaire<\/span>\n\t\t\t<\/h3>\n\t\t\n\t\t
    \n\t\t\t

    Nos th\u00e9rapies approuv\u00e9es aux \u00c9tats-Unis et dans d\u2019autres pays comprennent une s\u00e9rie de premi\u00e8res\u00a0: le premier traitement approuv\u00e9 au monde pour la dystrophie musculaire de Duchenne, la premi\u00e8re th\u00e9rapie g\u00e9nique approuv\u00e9e administr\u00e9e directement dans le cerveau et le premier modificateur d\u2019\u00e9pissage de petites mol\u00e9cules approuv\u00e9. Nous continuons d\u2019investir dans un portefeuille diversifi\u00e9 pour des maladies o\u00f9 les besoins ne sont pas combl\u00e9s.<\/p>\n\t\t<\/div>\n\n\t\t\n\t\t\t

    \n\n\t\t\t\t\tVoir nos m\u00e9dicaments au Canada<\/a>\n\t\t\n\t\t\n\t\t\n\t<\/div>\n\n\t<\/div>\n<\/div>\n\n\n\n\n\t\n<\/svg>\n\n\n\n
    \n
    \n
    <\/div>\n\n\n\n
    DOMAINES TH\u00c9RAPEUTIQUES<\/h6>\n\n\n\n

    Maladies au c\u0153ur de nos priorit\u00e9s<\/h2>\n<\/div>\n\n\n\n
    \n
    \"PKU<\/figure>\n\n\n\n

    Ph\u00e9nylc\u00e9tonurie (PCU)<\/h4>\n\n\n\n

    Affection m\u00e9tabolique caus\u00e9e par des mutations du l\u2019hydroxylase de la ph\u00e9nylalanine (PAH), une enzyme digestive cl\u00e9, qui entra\u00eene des troubles cognitifs et des crises convulsives.<\/p>\n<\/div>\n\n\n\n

    En savoir plus<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    DOMAINES TH\u00c9RAPEUTIQUES Maladies au c\u0153ur de nos priorit\u00e9s Ph\u00e9nylc\u00e9tonurie (PCU) Affection m\u00e9tabolique caus\u00e9e par des mutations du l\u2019hydroxylase de la ph\u00e9nylalanine (PAH), une enzyme digestive cl\u00e9, qui entra\u00eene des troubles cognitifs et des crises convulsives.<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-13","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nPage D'accueil - PTC Therapeutics (Canada-French)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ptcbio.ca\/fr\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Page D'accueil\" \/>\n<meta property=\"og:description\" content=\"DOMAINES TH\u00c9RAPEUTIQUES Maladies au c\u0153ur de nos priorit\u00e9s Ph\u00e9nylc\u00e9tonurie (PCU) Affection m\u00e9tabolique caus\u00e9e par des mutations du l\u2019hydroxylase de la ph\u00e9nylalanine (PAH), une enzyme digestive cl\u00e9, qui entra\u00eene des troubles cognitifs et des crises convulsives.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ptcbio.ca\/fr\/\" \/>\n<meta property=\"og:site_name\" content=\"PTC Therapeutics (Canada-French)\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T17:46:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/\",\"url\":\"https:\/\/www.ptcbio.ca\/fr\/\",\"name\":\"Page D'accueil - PTC Therapeutics (Canada-French)\",\"isPartOf\":{\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png\",\"datePublished\":\"2025-12-04T20:02:43+00:00\",\"dateModified\":\"2026-03-05T17:46:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ptcbio.ca\/fr\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#primaryimage\",\"url\":\"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png\",\"contentUrl\":\"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png\",\"width\":486,\"height\":486,\"caption\":\"PKU Patient\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ptcbio.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Page D’accueil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#website\",\"url\":\"https:\/\/www.ptcbio.ca\/fr\/\",\"name\":\"PTC Therapeutics (Canada-French)\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ptcbio.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#organization\",\"name\":\"PTC Therapeutics (Canada-French)\",\"url\":\"https:\/\/www.ptcbio.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/04\/ptcLogo.png\",\"contentUrl\":\"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/04\/ptcLogo.png\",\"width\":542,\"height\":542,\"caption\":\"PTC Therapeutics (Canada-French)\"},\"image\":{\"@id\":\"https:\/\/www.ptcbio.ca\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Page D'accueil - PTC Therapeutics (Canada-French)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ptcbio.ca\/fr\/","og_locale":"fr_CA","og_type":"article","og_title":"Page D'accueil","og_description":"DOMAINES TH\u00c9RAPEUTIQUES Maladies au c\u0153ur de nos priorit\u00e9s Ph\u00e9nylc\u00e9tonurie (PCU) Affection m\u00e9tabolique caus\u00e9e par des mutations du l\u2019hydroxylase de la ph\u00e9nylalanine (PAH), une enzyme digestive cl\u00e9, qui entra\u00eene des troubles cognitifs et des crises convulsives.","og_url":"https:\/\/www.ptcbio.ca\/fr\/","og_site_name":"PTC Therapeutics (Canada-French)","article_modified_time":"2026-03-05T17:46:35+00:00","og_image":[{"url":"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ptcbio.ca\/fr\/","url":"https:\/\/www.ptcbio.ca\/fr\/","name":"Page D'accueil - PTC Therapeutics (Canada-French)","isPartOf":{"@id":"https:\/\/www.ptcbio.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ptcbio.ca\/fr\/#primaryimage"},"image":{"@id":"https:\/\/www.ptcbio.ca\/fr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png","datePublished":"2025-12-04T20:02:43+00:00","dateModified":"2026-03-05T17:46:35+00:00","breadcrumb":{"@id":"https:\/\/www.ptcbio.ca\/fr\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ptcbio.ca\/fr\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.ptcbio.ca\/fr\/#primaryimage","url":"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png","contentUrl":"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/02\/Disease-in-focus-3.png","width":486,"height":486,"caption":"PKU Patient"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ptcbio.ca\/fr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ptcbio.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Page D’accueil"}]},{"@type":"WebSite","@id":"https:\/\/www.ptcbio.ca\/fr\/#website","url":"https:\/\/www.ptcbio.ca\/fr\/","name":"PTC Therapeutics (Canada-French)","description":"","publisher":{"@id":"https:\/\/www.ptcbio.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ptcbio.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.ptcbio.ca\/fr\/#organization","name":"PTC Therapeutics (Canada-French)","url":"https:\/\/www.ptcbio.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.ptcbio.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/04\/ptcLogo.png","contentUrl":"https:\/\/www.ptcbio.ca\/fr\/wp-content\/uploads\/sites\/28\/2026\/04\/ptcLogo.png","width":542,"height":542,"caption":"PTC Therapeutics (Canada-French)"},"image":{"@id":"https:\/\/www.ptcbio.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/pages\/13","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/comments?post=13"}],"version-history":[{"count":18,"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/pages\/13\/revisions"}],"predecessor-version":[{"id":17835,"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/pages\/13\/revisions\/17835"}],"wp:attachment":[{"href":"https:\/\/www.ptcbio.ca\/fr\/wp-json\/wp\/v2\/media?parent=13"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}